Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q1 2021 Earnings

13MayExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-31.5
-26
-20.5
-15

Details

Expected EPS
-15
Actual EPS
-25.5
Surprise EPS
-10.5
Surprise Percent
+70%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -25.5 per share for Q1 2021.

0 Comments

Share your thoughts